Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial. [electronic resource]
Producer: 20020125Description: 1171-4 p. digitalISSN:- 0885-3185
- Aged
- Carbamates -- therapeutic use
- Caregivers -- psychology
- Cognition Disorders -- drug therapy
- Female
- Follow-Up Studies
- Hallucinations -- drug therapy
- Humans
- Male
- Middle Aged
- Neuroprotective Agents -- therapeutic use
- Parkinson Disease -- psychology
- Phenylcarbamates
- Psychotic Disorders -- drug therapy
- Rivastigmine
- Stress, Psychological
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.